AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Acupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung Cancer

RecruitingNAAges 18 Years - 75 YearsAllXiu Huang
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This single-center, randomized, controlled study evaluates whether acupoint application added to standard 5-HT3 receptor antagonist anti-nausea medication improves control of chemotherapy-induced nausea and vomiting in adults with lung cancer receiving first-line platinum-based chemotherapy. Participants will be randomly assigned to receive either acupoint application plus a 5-HT3 receptor antagonist or the 5-HT3 receptor antagonist alone for one chemotherapy cycle. The study will compare complete control of delayed nausea and vomiting between the two groups.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Pathologically or cytologically confirmed lung cancer. * Scheduled to receive first-line platinum-based chemotherapy. * Aged 18 to 75 years. * Karnofsky Performance Status (KPS) score โ‰ฅ 60. * Expected survival โ‰ฅ 3 months. * Voluntarily signed written informed consent. Exclusion Criteria: * Known allergy to any component of the acupoint plaster. * Severe skin disease, infection, or breakdown at the planned acupoint sites. --Pregnant or lactating women. * Cognitive impairment or psychiatric disorder that prevents completion of study assessments. * Participation in another interventional clinical trial within 30 days prior to enrollment.
๐Ÿ’Š

What it tests

  • 5-HT3 receptor antagonist (e.g., ondansetron)
  • Acupoint application
๐Ÿ“

Where

1 site
The Affiliated Yongchuan Hospital of Chongqing Medical University
Chongqing, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy